Procurement Regimes and Medical Innovation

Procurement Regimes and Medical Innovation

Why has medical innovation brought cost-increasing enhancements to quality, rather than cost-reducing advances in productivity? The column uses a new dataset drawn from patents for prosthetic devices to show that the design of incentives for innovators can have substantial effects on these margins. Fixed-price procurement arrangements induce greater effort to reduce production costs than cost-plus procurement arrangements. Procurement models may therefore inadvertently lead to 'missing innovations'.

Healthcare spending has risen substantially since 1960. In the US, spending has risen from 5% to nearly 18% of GDP, while across the UK, France, Germany, and Japan, it has risen, on average, from just under 4% to just under 11% of GDP. Research has long connected this growth in cost to medical innovation (Smith et al. 2009, Cutler 2004).  



Next Article

Did you find this useful?

Medigy Innovation Network

Connecting innovation decision makers to authoritative information, institutions, people and insights.

Medigy Logo

The latest News, Insights & Events

Medigy accurately delivers healthcare and technology information, news and insight from around the world.

The best products, services & solutions

Medigy surfaces the world's best crowdsourced health tech offerings with social interactions and peer reviews.


© 2024 Netspective Media LLC. All Rights Reserved.

Built on May 29, 2024 at 11:21am